IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 83 filers reported holding IGM BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,815,891 | -38.5% | 456,993 | -32.0% | 0.00% | 0.0% |
| Q2 2023 | $6,204,304 | +14.7% | 672,189 | +70.8% | 0.00% | 0.0% |
| Q1 2023 | $5,406,882 | +59.8% | 393,514 | +97.8% | 0.00% | 0.0% |
| Q4 2022 | $3,383,731 | -40.3% | 198,926 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $5,668,000 | +58.4% | 249,269 | +25.5% | 0.00% | 0.0% |
| Q2 2022 | $3,579,000 | -68.7% | 198,554 | -53.6% | 0.00% | -50.0% |
| Q1 2022 | $11,443,000 | -3.3% | 428,087 | +6.1% | 0.00% | 0.0% |
| Q4 2021 | $11,838,000 | -55.7% | 403,624 | -0.7% | 0.00% | -66.7% |
| Q3 2021 | $26,730,000 | -24.0% | 406,480 | -3.9% | 0.01% | -25.0% |
| Q2 2021 | $35,184,000 | -38.0% | 422,883 | -42.9% | 0.01% | -42.9% |
| Q1 2021 | $56,775,000 | +213.2% | 740,310 | +260.6% | 0.01% | +180.0% |
| Q4 2020 | $18,127,000 | +309.0% | 205,318 | +241.9% | 0.01% | +400.0% |
| Q3 2020 | $4,432,000 | -6.1% | 60,054 | -7.1% | 0.00% | 0.0% |
| Q2 2020 | $4,719,000 | +386.0% | 64,645 | +18.2% | 0.00% | – |
| Q3 2019 | $971,000 | – | 54,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |